Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Titel:
Treatment With 25-Hydroxyvitamin D3 (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Auteur:
Maghbooli, Zhila Sahraian, Mohammad Ali Jamalimoghadamsiahkali, Saeidreza Asadi, Asma Zarei, Azadeh Zendehdel, Abolfazl Varzandi, Tarlan Mohammadnabi, Sara Alijani, Neda Karimi, Mehrdad Shirvani, Arash Holick, Michael F.